Ventyx Biosciences's market cap is currently $215.71M. The company's EPS TTM is $-0.38; its P/E ratio is ―; Ventyx Biosciences is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.45. See an overview of income statement, balance sheet, and cash flow financials.
